Curis
CRIS
#11067
Rank
NZ$8.1 M
Marketcap
NZ$0.85
Share price
-23.59%
Change (1 day)
-57.67%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): NZ-$24.95

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$25.81. In 2025 the company made an earnings per share (EPS) of NZ-$43.22 an increase over its 2024 EPS that were of NZ-$255.20.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$24.95-42.27%
2025NZ-$43.22-83.07%
2024NZ-$255.20-22.15%
2023NZ-$327.81-26.17%
2022NZ-$443.9722.3%
2021NZ-$363.02-25.37%
2020NZ-$486.45-30.93%
2019NZ-$704.26-2.02%
2018NZ-$718.78
2016NZ-$1,634-10%
2015NZ-$1,815138.1%
2014NZ-$762.3440%
2013NZ-$544.53-25%
2012NZ-$726.0466.67%
2011NZ-$435.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.29-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.20-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.65-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$6.28-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.90-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$5.77-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$9.15-64.56%๐Ÿ‡บ๐Ÿ‡ธ USA